Liquidation Price: $32,975.00

Original Price: $85,000.00

Percent Discount: 61%

This product sold on June 7th, 2017.

 

Product Specifications
Laser Type	Focus Field Radio Frequency
Max. Power	200 Watts
Output Frequency	27.12 MHz
Treatment Duration	1 to 30 min
Mode	Continuous
Output Power	0 W - 200 W
Dimensions of Device	22 in W x 39 in H x 22 in D
Weight of Device	84 lbs
Graphic Color Touch Screen	8.4", 640x480 pixels
Dimensions of Applicator without Cable	27 in W x 7.6 in H x 4.1 in
Weight of Applicator 3.9 lbs

 

Manufacturer Notes

Non-invasive procedure with the largest treatment area in the industry No anesthesia or pain medication No downtime & unsurpassed ease of use No costly disposables No hour limits pre-loaded on the machine, Operator simplified protocols Consistent and measurable results Total patient comfort with unsurpassed patient compliance Short treatment times Rapid return on investment Vanquish uses real-time impedance tuning circuitry. This design helps target the thermal effect into deep tissue while protecting the surrounding layers What is the Vanquish Procedure The Vanquish system is a non-invasive, non-contact Selective RF Technology that selectively heats adipose tissue to the point of apoptosis, while the surrounding tissue remains unaffected. The result is a safe and natural decrease in the adipose tissue layer. How Does the Vanquish Procedure Work? The Vanquish delivers energy based on the impedance of adipose tissue. The device constantly adjusts energy delivery in order to induce and maintain homogeneous heating of the tissue. Once the adipocytes reach therapeutic temperature, the adipocytes will become apoptotic, resulting in the cell death. How Hot is Hot? Fat cells have lower conductivity than the surrounding tissue such as skin and muscles. The Vanquish is able to selectively heat the fat cells to the temperature of 44 - 45°C while the surrounding tissue remains unaffected at 40 - 41°C. Who developed the Vanquish procedure? Apoptosis is the process of programmed cell changes and death that may occur in multicellular organisms. In contrast to necrosis, which is a form of traumatic cell death that results from acute cellular injury, apoptosis generally confers advantages during an organism's life cycle. Unlike necrosis, apoptosis produces cell fragments called apoptotic bodies that phagocytic cells are able to engulf and quickly remove before the contents of the cell can spill out onto surrounding cells and cause damage. Research in and around apoptosis has increased substantially since the early 1990s. Fat cells are vulnerable to the effects of selective heating. Their initial evidence, published in Lasers in Surgery and Medicine in 2013, concluded that controlled local tissue heating can induce selective fat cell reduction and subsequent loss of subcutaneous fat without damaging other tissue layers. This led to the development of the patented selective RF technology behind the non-invasive Vanquish procedure. Who stands behind the Vanquish? Established in 1993, BTL has become one of the major world manufacturers of medical devices. BTL’s primary segments include cardiology, such as holter monitoring and stress test systems, PT, pneumology, and medical aesthetics. The BTL’s aesthetic division manufactures non-surgical aesthetic devices that represent the best in body contouring, fat reduction, skin tightening and anti-wrinkle and anti-cellulite care. The BTL manufacturing and R&D facilities have been ISO 13485 and Canadian CMDCAS certified. The BTL products are CE marked and many of them have been cleared by the Health Canada, US FDA, as well as by a number of other regulatory bodies. How is the Vanquish treatment performed? After the patient is positioned comfortably, the applicator is placed over the treatment area. This is a non-contact procedure, therefore, the device does not come in direct contact with the patient. Once the treatment begins the device measures the impedance of the tissue and begins to "tune" to the adipose tissue. The treatment provider will monitor the patient response and tuning throughout the treatment. The abdomen and love handles are treated for 30 minutes. What results can my patients expect to see? After a series of four 30 minute treatments, clinical studies demonstrate that the Vanquish procedure produces consistent visible and measurable results, with high patient satisfaction. How does the Vanquish compare with other technologies? The Vanquish is the first non-contact, hands-free body contouring device on the market. Unlike other non-invasive procedures, the Vanquish is pain free and easy to operate. There is no risk of operator fatigue and because of the ease of application, there is very little room for human error. This means consistent results. Unlike other non-invasive devices that require multiple small treatment areas and lengthy treatment sessions, the Vanquish provides the largest treatment area in the industry, all in 30 minutes. What are the common side effects after the procedure? Patients are able to return immediately to their daily routine. Side effects are minimal and transient and include mild redness, warmth, and tissue tenderness. These side effects last minutes or up to an hour post treatment. Who is a suitable candidate for treatment? The Vanquish is for patients who have areas of unwanted fat.